investor.oxigene.com
Investors & Media | OxigeneThe Investor Relations website contains information about OXiGENE, Inc. business for stockholders, potential investors, and financial analysts.
http://investor.oxigene.com/
The Investor Relations website contains information about OXiGENE, Inc. business for stockholders, potential investors, and financial analysts.
http://investor.oxigene.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
5
SITE IP
206.200.251.19
LOAD TIME
0 sec
SCORE
6.2
Investors & Media | Oxigene | investor.oxigene.com Reviews
https://investor.oxigene.com
The Investor Relations website contains information about OXiGENE, Inc. business for stockholders, potential investors, and financial analysts.
Ormat Technologies Inc. | Corporate Profile
Join our Q2 2015 earnings call on Aug 4 at 9 AM EDT. Q2 2015 Earnings Call. As of August 7, 2015 -. Minimum 20 minute delay. In addition to owning and operating geothermal power plants in the United States and other countries, the Company designs, manufactures and sells power generating equipment as well as complete power plants on a turnkey basis. Ormat currently has operations in the United States, Guatemala and Kenya. Ormat Technologies Reports 2015 Second Quarter Results. Ormat Technologies, Inc....
investor.oshkoshcorporation.com
Oshkosh Corporation - Investors - Overview
Mar 29, 2018 04:02 PM. Pricing delayed 20 minutes. Annual and Quarterly Reports. Oshkosh Corporation Tax Strategy. Annual and Quarterly Reports. Oshkosh Corporation Tax Strategy. Enter the code shown above. Unsubscribe from email alerts. Oshkosh, WI 54903-2566. Oshkosh Corporation - A Different Integrated Global Industrial. Oshkosh Corporation - A Different Integrated Global Industrial. Oshkosh Corporation - A Different Integrated Global Industrial. Annual and Quarterly Reports. 2017 Annual Report (PDF 2...
Investor Relations | Osiris Therapeutics, Inc.
Skip to main navigation. Osiris Appoints Willi Miesch to its Board of Directors, Change in CEO. Osiris Therapeutics, Inc. Announces Resolution of SEC Investigation. 03/22/16 10:00 AM EDT. Alliance Regenerative for Medicine - 4th Annual Cell and Gene Investor Day. News and Events submenu. Financials and Filings submenu. 03/29/18 11:49 pm EDT. Stock Information sub menu. Check Our FAQs and if you still have questions please contact us. Osiris Therapeutics, Inc.
Owens Corning - Investors - Overview
Skip to main content. Total Protection Roofing System. Find an Insulation Professional. Learn how to Install. Commercial and Institutional Insulation. Commercial Insulation Product List. Architectural and Engineering Information Center. Find a Sales Representative. Consumer Goods, Electrical and Electronics. Interns and New Grads. As we enter 2018, we are well positioned to deliver strong results and build value for our company. Mike Thaman - Chairman and Chief Executive Officer. March 29, 2018. Leader, ...
Investor Relations | Oxford Industries Inc.
Skip to main navigation. SEC and Financial Information. SEC and Financial Information. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Oxford Industries, Inc.'s financial performance into perspective. Oxford Reports Fourth Quarter and Full Fiscal Year 2017 Results. Oxford to Release Fourth Quarter and Fiscal 2017 Results on March 28, 2018. Mar 28,2018 4:30 PM.
Investors & Media | Oxigene
Efficiently Creating Value with Innovative Science. Day High: 1.35. Day Low: 1.27. Aug 7, 2015. Delayed 20 min., by eSignal. OXiGENE is highly committed to delivering value to its shareholders. Were working to translate innovative science into important, next-generation therapeutic products that deliver significant medical benefits to patients suffering from cancer. Our pipeline currently includes fosbretabulin and other preclinical and clinical stage therapeutic candidates. Aug 4, 2015. Jul 28, 2015.
investor.pacificbiosciences.com
INVESTOR RELATIONS | Pacific Biosciences of California
Skip to main navigation. ANNUAL REPORT and PROXY MATERIALS. Is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research. Pacific Biosciences of California, Inc. Fourth Quarter 2017 Earnings Conference Call. Feb 1, 2018 1:30 PM PST. 36th Annual JP Morgan Healthcare Conference. Jan 8 11, 2018. Westin St. Francis. Piper Jaffray 29th Annual Healthcare Confernce. Nov 28 29, 2017.
Pacific Web Works, Inc.
If you are not taken to our investor section after 10 seconds click here.
Investors & Media - Company Overview - Pacira Pharmaceuticals, Inc.
10450 Science Center Drive. San Diego, CA 92121. Parsippany, NJ 07054. Q2 2015 Pacira Pharmaceuticals, Inc. Earnings Conference Call. 160;at 9:00 am ET. Q2 2015 Pacira Pharmaceuticals, Inc. Earnings Conference Call. Thursday, July 30, 2015 . 9:00 am ET . Click here for webcast. Click here to add this event to your calendar. Pacira Pharmaceuticals, Inc. at 2015 Wedbush PacGrow Healthcare Conference. 160;at 8:00 am ET. Pacira Pharmaceuticals, Inc. at 2015 Wedbush PacGrow Healthcare Conference. PARSIPPANY,...
CORPORATE OVERVIEW | Pain Therapeutics, Inc.
Skip to main navigation. Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. Pain Therapeutics Stock Information. 12:38 AM EDT on Mar 30, 2018. Mar 19, 2018. Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER. Mar 01, 2018. FDA Accepts REMOXY NDA for Review, Sets PDUFA Date of August 7, 2018.
SOCIAL ENGAGEMENT